Lepu Biopharma
PublicLepu Biopharma is now publicly traded
The data on this page reflects Lepu Biopharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Feb 23, 2022
Last Round
Private Placement
May 17, 2024
Est. Valuation at Exit
$1.15B
Total Funding Raised
$505.09M
Company Overview
Lepu Biopharma is a biopharmaceutical company that focuses on the discovery, development, and commercialization of oncology therapeutics, including targeted therapies and immunotherapies.
Sector
Biotech
AI Layer
Application
Keywords
Lepu Biopharma Comparables
Compare Lepu Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Overland ADCT BioPharma | 76% |
Lepu Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | May 17, 2024 | ||||
| IPO | Feb 23, 2022 | ||||
| Series C | Apr 20, 2021 | ||||
| Series B | Aug 19, 2020 | ||||
| Series A | Jul 1, 2019 |
Lepu Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Development Bank Capital | Series A |
| Huatai International | IPO |
| China International Capital Corporation | IPO |
| Tiger Brokers | IPO |
| Morgan Stanley | IPO |
| Ping An Capital | Series B |
| Shiyu Capital | Series A |
Lepu Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access